Crossref
DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2
Acta Poloniae Pharmaceutica - Drug Research · 2019
DOI: 10.32383/appdr/102651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, 2019. Verfasst von Diaa Ibrahim und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ibrahim, D., Radini, I., & KHIDRE, R. (2019). DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2. Acta Poloniae Pharmaceutica - Drug Research. https://doi.org/10.32383/appdr/102651
Vancouver
Ibrahim D, Radini I, KHIDRE R. DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2. Acta Poloniae Pharmaceutica - Drug Research. 2019. doi:10.32383/appdr/102651
BibTeX
@article{Ibrahim2019,
author = {Ibrahim, Diaa and Radini, Ibrahim and KHIDRE, Rizk},
title = {DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2},
journal = {Acta Poloniae Pharmaceutica - Drug Research},
year = {2019},
doi = {10.32383/appdr/102651}
}
EUVIMED